Hemp Ban Extension Passes House: December 11 Deadline

Loading market data

The U.S. House of Representatives has passed a continuing resolution that extends the current hemp legal framework until December 11, moving the previous November 12 deadline.

The vote, which carried 370-48, provides temporary relief for the hemp industry but sets the stage for intense lobbying and legislative negotiations over the next few months.

While the extension offers a brief reprieve, industry leaders caution against celebrating too early. The real work lies ahead: defining what federal regulation of hemp-derived cannabinoids will look like, closing loopholes, and aligning stakeholders behind viable legislation.

Synthetic Cannabinoids Face Expiry

One crucial detail embedded in the CR is that synthetic cannabinoids will not receive an extension and remain set to become illegal on November 11. Only non-synthetic hemp cannabinoids gain the additional time.

This distinction addresses one key loophole the industry has worked to close, but more work remains to craft a regulatory framework acceptable to lawmakers and stakeholders.

Key Legislative Proposals on the Table

Multiple bills are circulating, each with different approaches to regulating hemp:

The Bar bill (sponsored by Rep. Andy Barr) closes the THCA loophole by raising the limit from 0.3% to 1% but under a total THC standard—a change that directly targets THCA flower products. If this language gains traction, businesses in the THCA flower market could face significant disruption.
The Van Dyne bill focuses exclusively on beverages. It offers no room for CBD oils, topicals, supplements, or pet products—segments that founded the modern hemp industry. Both bills include tax components aimed at parity with beverage alcohol, but tax reform is unlikely to pass before December.
On the Senate side, a states-rights bill introduced earlier by Sens. Amy Klobuchar and Rand Paul was initially dismissed as a dead letter. However, it has gained renewed interest as a possible vehicle for allowing states to manage hemp commerce independently, even if federal rules remain unsettled.

Industry Leaders Push for Incremental Progress

Jim Higdon, co-founder and chief communications officer at Cornbread Hemp, underscored that meaningful regulation will not happen overnight. “We’re never going to get a perfect bill landing out of the sky,” he noted.

He expects an incremental approach, prioritizing elements like a potency cap and a shift to total THC measurement—fixing the 2018 Farm Bill’s oversights.

Higdon also predicted that smokable and inhalable hemp products may not survive the coming scrutiny.

In states like Florida and Texas, the absence of strict oversight has led to a chaotic market, but Kentucky’s hemp program never permitted smokables, offering a contrasting model.

No Further Extensions Expected

The White House has reportedly told lawmakers central to CR negotiations that no additional extension will follow December 11. That stance pressures the industry to achieve meaningful regulatory milestones this calendar year.

Higdon emphasized the importance of working in good faith with concerned senators to secure what can be accomplished now, while leaving tax and interstate commerce issues for 2026.

Building Bridges Between Hemp and Cannabis

A central theme emerging from the debate is preserving interstate commerce for hemp-derived products while also opening doors for the regulated cannabis market. Higdon suggested that converted cannabinoids—like CBD-derived CBN—are essential to supply beverage and edible markets, and ensuring safe, regulated access benefits both industries.

He also expressed surprise that some multi-state operators (MSOs) have curtailed hemp programs at a time when clarity is finally approaching. Higdon viewed this as a possible resource reallocation rather than a strategic retreat, perhaps influenced by progress on cannabis rescheduling and the broader performance of tracked index funds like the Roundhill Cannabis ETF (WEED).

Coinasity's Take

The December 11 deadline creates both urgency and opportunity. The hemp industry has a narrow window to negotiate a workable framework, but the path forward is far from unified. Divergent bills reflect competing priorities—beverage-only versus full-spectrum regulation, state rights versus federal standards.

As echoed in recent industry community discussions, the most likely outcome appears to be a hybrid bill that addresses the most pressing concerns: setting a total THC potency cap, age-gating products, enforcing GMP standards, and safeguarding domestic hemp production. Tax parity and broader cannabis integration will likely wait until next year.

For businesses, the message is clear: the status quo is ending. Companies that prepare for stricter federal oversight—especially around total THC limits and manufacturing standards—will be better positioned to thrive once the regulatory dust settles. The industry’s ability to unify behind a single proposal will determine whether December brings clarity or confusion.